Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis.
Schulman-Marcus, Joshua; Prabhakaran, Dorairaj; Gaziano, Thomas A.
BMC Cardiovasc Disord
; 10: 13, 2010 Mar 12.
Artigo em Inglês | MEDLINE | ID: mdl-20222987
Analiz «vliyaniya na byudzhet¼ primeneniya antitrombotsitarnoi terapii tikagrelorom i klopidogrelom u patsientov s ostrym koronarnym sindromom, perenesshikh operatsiyu koronarnogo shuntirovaniya.
Angina and associated healthcare costs following percutaneous coronary intervention: A real-world analysis from a multi-payer database.
Clinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: results from the multinational APTOR registry.
Toward the single-hour high-quality genome.
Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial.
The talk test-A costless tool for exercise prescription in Indian cardiac rehabilitation.
Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
Cost of Operating Central Cancer Registries and Factors That Affect Cost: Findings From an Economic Evaluation of Centers for Disease Control and Prevention National Program of Cancer Registries.
Catastrophic health expenditure & coping strategies associated with acute coronary syndrome in Kerala, India.
Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?